Introducing New Treatment for Cancer. Practical, Ethical and Legal Problems

por Cullen, M.H.
Publicado 1992

Reply to the letter from Dr Colls

por Cullen, M.H.
Publicado 1994

Long-term toxicity of chemotherapy for testicular cancer--the cost of cure.

por Stuart, N. S., Woodroffe, C. M., Grundy, R., Cullen, M. H.
Publicado 1990

Management preferences in stage I non-seminomatous germ cell tumours of the testis: an investigation among patients, controls and oncologists.

por Cullen, M. H., Billingham, L. J., Cook, J., Woodroffe, C. M.
Publicado 1996

Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compare.

por Cullen, M. H., Joshi, R., Chetiyawardana, A. D., Woodroffe, C. M.
Publicado 1988

A phase II study of carboplatin in adenocarcinoma of the oesophagus.

por Steel, A., Cullen, M. H., Robertson, P. W., Matthews, H. R.
Publicado 1988

A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical researc...

por Mead, G M, Cullen, M H, Huddart, R, Harper, P, Rustin, G J S, Cook, P A, Stenning, S P, Mason, M
Publicado 2005

The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial.

por O'Brien, M. E., Cullen, M. H., Woodroffe, C., Kelly, K., Burman, C., Palmer, K., Stuart, N. S., Blackledge, G. R., Sharpe, J.
Publicado 1989

A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma

por Horwich, A, Oliver, R T D, Wilkinson, P M, Mead, G M, Harland, S J, Cullen, M H, Roberts, J T, Fossa, S D, Dearnaley, D P, Lallemand, E, Stenning, S P
Publicado 2000

ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymp...

por Hancock, B W, Gregory, W M, Cullen, M H, Hudson, G Vaughan, Burton, A, Selby, P, Maclennan, K A, Jack, A, Bessell, E M, Smith, P, Linch, D C
Publicado 2001

Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)

por Dearnaley, D P, Fossa, S D, Kaye, S B, Cullen, M H, Harland, S J, Sokal, M P J, Graham, J D, Roberts, J T, Mead, G M, Williams, M V, Cook, P A, Stenning, S P
Publicado 2005

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours

por Fosså, S D, Stenning, S P, Gerl, A, Horwich, A, Clark, P I, Wilkinson, P M, Jones, W G, Williams, M V, Oliver, R T, Newlands, E S, Mead, G M, Cullen, M H, Kaye, S B, Rustin, G J S, Cook, P A
Publicado 1999